Table of Content



1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation

2. South Africa Central Nervous System (CNS) Therapeutic Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South Africa Central Nervous System (CNS) Therapeutic Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South Africa PEST Analysis
4.3 Expert Opinions

5. Central Nervous System (CNS) Therapeutic Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of CNS Disorders
5.2 Key Market Restraints
5.2.1 High Cost of Treatment
5.3 Key Market Opportunities
5.3.1 Increase in Geriatric Population And Associated Diseases
5.4 Future Trends
5.4.1 Increasing Wearable Devices for Central Nervous System (CNS)
5.5 Impact Analysis

6. South Africa Central Nervous System (CNS) Therapeutic Market - South Africa Market Analysis
6.1 Overview
6.2 South Africa Central Nervous System (CNS) Therapeutic Market - Revenue Forecasts and Analysis - 2018- 2027

7. South Africa Central Nervous System (CNS) Therapeutic Market Analysis- by Disease Type
7.1 Overview
7.2 South Africa Central Nervous System (CNS) Therapeutic Market, By Disease Type 2018 & 2027 (%)
7.3 Neurovascular Diseases Market
7.3.1 Overview
7.3.2 South Africa Neurovascular Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Degenerative Disorders Market
7.4.1 Overview
7.4.2 South Africa Degenerative Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Mental Health Market
7.5.1 Overview
7.5.2 South Africa Mental Health Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Trauma Market
7.6.1 Overview
7.6.2 South Africa Trauma Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Others Market
7.7.1 Overview
7.7.2 South Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)

8. South Africa Central Nervous System (CNS) Therapeutic Market Analysis- by Drug Type
8.1 Overview
8.2 South Africa Central Nervous System (CNS) Therapeutic Market, By Drug Type 2018 & 2027 (%)
8.3 Analgesics Market
8.3.1 Overview
8.3.2 South Africa Analgesics Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Anesthetics Market
8.4.1 Overview
8.4.2 South Africa Anesthetics Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Anti-Parkinson Drugs Market
8.5.1 Overview
8.5.2 South Africa Anti-Parkinson Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Anti-Epileptics Drugs Market
8.6.1 Overview
8.6.2 South Africa Anti-Epileptics Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Others Drugs Market
8.7.1 Overview
8.7.2 South Africa Others Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

9. South Africa Central Nervous System (CNS) Therapeutic Market Analysis- by Distribution Channel
9.1.1 Overview
9.1.2 South Africa Central Nervous System (CNS) Therapeutic Market, By Distribution Channel 2018 & 2027 (%)
9.1.3 Hospital Pharmacies Market
9.1.4 Overview
9.1.5 South Africa Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6 Retail Pharmacies Market
9.1.6.1 Overview
9.1.6.2 South Africa Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

10. Central Nervous System (CNS) Therapeutic Market - Industry Landscape
10.1 Overview
10.2 Growth Strategies done by the companies in the Market, (%)
10.3 Organic Developments
10.3.1 Overview
10.4 Inorganic developments
10.4.1 Overview

11. Central Nervous System (CNS) Therapeutic Market-Key Company Profiles
11.1 Eli Lilly and company
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Pfizer Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Merck & Co., Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 AstraZeneca
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Novartis AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Information
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Takeda Pharmaceutical Company Limited
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Information
11.6.4 Product Pipeline
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Lundbeck
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Adcock Ingram
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Lupin Limited
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Information
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments

12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms



List of Figures


Figure 1. Central Nervous System (CNS) Therapeutic Market Segmentation
Figure 2. South Africa Central Nervous System (CNS) Therapeutic Market Overview
Figure 3. Mental Health Disease Segment Held Largest Share Of The Disease Type Segment In Central Nervous System (CNS) Therapeutic Market
Figure 4. South Africa Nervous System (CNS) Therapeutic Market, Industry Landscape
Figure 5. South Africa: PEST Analysis
Figure 6. Impact Analysis of Driver and Restraints Pertaining to Central Nervous System (CNS) Therapeutic Market
Figure 7. South Africa Central Nervous System (CNS) Therapeutic Market - Revenue Forecasts and Analysis - 2018- 2027
Figure 8. South Africa Central Nervous System (CNS) Therapeutic Market, by Disease Type 2018 & 2027 (%)
Figure 9. South Africa Neurovascular Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 10. South Africa Degenerative Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. South Africa Mental Health Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. South Africa Trauma Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. South Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. South Africa Central Nervous System (CNS) Therapeutic Market, by Drug Type 2018 & 2027 (%)
Figure 15. South Africa Analgesics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. South Africa Anesthetics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. South Africa Anti-Parkinson Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. South Africa Anti-Epileptics Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. South Africa Others Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. South Africa Central Nervous System (CNS) Therapeutic Market, by Distribution Channel 2018 & 2027 (%)
Figure 21. South Africa Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. South Africa Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Growth Strategies done by the companies in the Market, (%)


List of Tables


Table 1. Organic Developments Done By Companies
Table 2. Inorganic developments done by Companies
Table 3. Glossary of Terms, Central Nervous System (CNS) Therapeutic Market